Phastar and Medrio have been partnering together on trials for the past 3 years, culminating in a unique way to visualize clinical trial data. Through the use of Medrio’s API, Phastar has built a data visualization tool that reduces risk and allows for complete study oversight. In this podcast we’ll discuss the need for data visualization in clinical trials, how Phastar has continued their trials during a global pandemic, and what their thoughts are on the future of how we collect and view data.
Approximately 39.5% of all men and women will be diagnosed with cancer at some point during their lifetimes, and yet only 8% of oncology...
Reducing the number of vendors you interact with allows you to not only achieve higher quality data, you can also spend more time focusing...
Patients are no longer passive research subjects, but rather being integrated into the research process from the start. Patient advocates help with such integrations,...